STEPHANIE KEESEE APRN-CNP NPI 1699150052

NPI Details

Stephanie Keesee, APRN-CNP is a family nurse practitioner in Holdenville, OK with 13 years of experience. Stephanie Keesee, APRN-CNP NPI is 1699150052. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

201 N HINCKLEY ST
HOLDENVILLE, OK
ZIP 74848
Phone: (405) 712-5080
Fax: (833) 254-2642

The NPI 1699150052 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative (HCPCS:86328)
• Evaluation of use of breathing device (HCPCS:94664)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)

The enumeration date for this NPI number is 7/28/2015 and was last updated on 6/29/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.